Equities research analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens boosted their price target on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
Read Our Latest Stock Report on MDRX
Veradigm Stock Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Top Biotech Stocks: Exploring Innovation Opportunities
- How to Protect Your Portfolio When Inflation Is Rising
- What is the S&P/TSX Index?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Learn Technical Analysis Skills to Master the Stock Market
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
